Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

CHE lifts notice of withdrawal of UFS LLB degree’s accreditation status
2017-11-16


The Council on Higher Education (CHE) has lifted the notice of withdrawal of the accreditation status of the University of the Free State’s (UFS) LLB degree. The degree is conditionally accredited with a progress report required in October 2018.

The Faculty of Law received this response to its Improvement Plan for the LLB degree from the CHE on 14 November 2017.

During 2016, a national review was conducted on all LLB programmes in order to strengthen the quality of legal education provision at all South African universities. On 30 March 2017, the Higher Education Quality Committee (HEQC) approved the findings of the National Reviews Committee (NRC) with regard to the LLB programme at the UFS, and placed the qualification on a notice of withdrawal of accreditation.

The decision of the CHE this week comes after the faculty submitted the Improvement Plan during early October 2017. This plan sets out for the CHE the changes that will be effected in the LLB programme for 2018 and 2019 and provides an outline of the new LLB curriculum it intends to introduce in 2020.

“The university’s executive management is extremely pleased about the outcome and welcomes the lifting of the notice of withdrawal of accreditation status, as it comes during a critical time of the year when the new cohort of Law students is completing their Grade 12 exams. Prof Caroline Nicholson, Dean of the Faculty of Law, and her team are commended for the considerable effort put into the submission and the extensive attention that was specifically given to concerns raised by the CHE in terms of the number of credits in the degree,” says Prof Francis Petersen, Rector and Vice-Chancellor of the UFS. 

“There is hard work to be done going forward in ensuring that the UFS LLB degree is the very best on offer in South Africa, but with the continued support and commitment of the staff and students in the Faculty of Law, this vision is achievable,” says Prof Nicholson.

 

Released by:
Lacea Loader (Director: Communication and Brand Management)
Telephone: +27 51 401 2584 | +27 83 645 2454
Email: news@ufs.ac.za | loaderl@ufs.ac.za
Fax: +27 51 444 6393

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept